B 300 Pill: white, capsule/oblong, 18mm
The pill with imprint B 300 (White, Capsule/Oblong, 18mm) has been identified as Diltiazem Hydrochloride Extended-Release 300 mg and is used for Atrial Fibrillation, Atrial Flutter, High Blood Pressure, Heart Failure, and Angina Pectoris Prophylaxis. It belongs to the drug classes calcium channel blockers, group IV antiarrhythmics and is not a controlled substance.
Images for B 300
Diltiazem Hydrochloride Extended-Release
- Imprint
- B 300
- Strength
- 300 mg
- Color
- White
- Size
- 18.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Calcium channel blockers, Group IV antiarrhythmics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Oceanside Pharmaceuticals
- Inactive Ingredients
-
carnauba wax,
silicon dioxide,
croscarmellose sodium,
hypromelloses,
magnesium stearate,
microcrystalline cellulose,
microcrystalline wax,
polydextrose,
polyethylene glycol,
polysorbate 80,
povidone,
sucrose stearate,
magnesium silicate,
titanium dioxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00074-3063 (Discontinued) | Abbott Laboratories |
| 00187-2048 | Bausch Health Companies Inc. |
| 68682-0707 | Oceanside Pharmaceuticals, Inc. |
Related images for "B 300"
More about diltiazem
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (192)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: calcium channel blockers
- Breastfeeding
Patient resources
Other brands
Cardizem, Cartia XT, Dilt-XR, Matzim LA, ... +5 more
Professional resources
- Diltiazem Hydrochloride monograph
- Diltiazem (FDA)
- Diltiazem CD (FDA)
- Diltiazem Extended Release Tablets (FDA)
- Diltiazem Injection (FDA)
- Diltiazem Tablets (FDA)
Other brands
Cardizem, Cartia XT, Dilt-XR, Tiadylt ER, ... +6 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.